Published in Arch Ophthalmol on February 01, 1996
Topography of diabetic macular edema with optical coherence tomography. Ophthalmology (1998) 5.00
Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy. Neoplasia (2000) 2.84
Optic disc pit: a review. Graefes Arch Clin Exp Ophthalmol (2011) 2.28
The etiology and treatment of macular detachment associated with optic nerve pits and related anomalies. Trans Am Ophthalmol Soc (1998) 1.89
Vitreous findings in optic disc pit maculopathy based on optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2007) 1.53
Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol (2007) 1.46
Optical coherence tomography of pneumatic displacement of optic disc pit maculopathy. Br J Ophthalmol (1998) 1.16
Macular retinoschisis associated with normal tension glaucoma. Graefes Arch Clin Exp Ophthalmol (2011) 1.15
Optical coherence tomography in optic pit maculopathy managed with vitrectomy-laser-gas. Graefes Arch Clin Exp Ophthalmol (2004) 1.08
Peripapillary retinoschisis in glaucomatous eyes. PLoS One (2014) 1.06
Restoration of the photoreceptor layer and improvement of visual acuity in successfully treated optic disc pit maculopathy: a long follow-up study by optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2012) 1.00
STRATUS optical coherence tomography in unilateral colobomatous excavation of the optic disc and secondary retinoschisis. Graefes Arch Clin Exp Ophthalmol (2004) 0.99
Long-term outcomes of pars plana vitrectomy without internal limiting membrane peeling for optic disc pit maculopathy. Eye (Lond) (2013) 0.95
Heterozygous triplication of upstream regulatory sequences leads to dysregulation of matrix metalloproteinase 19 in patients with cavitary optic disc anomaly. Hum Mutat (2015) 0.92
Optical coherence tomography in optic pit maculopathy. Int Ophthalmol (2007) 0.90
Clinical manifestations of optic pit maculopathy as demonstrated by spectral domain optical coherence tomography. Clin Ophthalmol (2013) 0.88
Swept-source optical coherence tomography identifies connection between vitreous cavity and retrobulbar subarachnoid space in patient with optic disc pit. Eye (Lond) (2013) 0.88
Multilayered retinoschisis associated with optic disc pit. Jpn J Ophthalmol (2005) 0.88
Optical coherence tomography before and after vitrectomy with internal limiting membrane removal in a child with optic disc pit maculopathy. Jpn J Ophthalmol (2005) 0.84
Optic disc pit with peripapillary retinoschisis presenting as a localized retinal nerve fiber layer defect. Korean J Ophthalmol (2011) 0.83
Dynamic atypical optic nerve coloboma associated with transient macular detachment. Trans Am Ophthalmol Soc (2005) 0.82
Optic disc pit maculopathy: when and how to treat? A review of the pathogenesis and treatment options. Int J Retina Vitreous (2015) 0.79
Peripapillary Retinoschisis in Glaucoma Patients. J Ophthalmol (2016) 0.79
Comparison of visual evoked potentials and retinal nerve fiber layer thickness in Alzheimer's disease. Front Neurol (2013) 0.77
Double-vitrectomy for optic disc pit maculopathy. Case Rep Ophthalmol (2012) 0.76
[Optical coherence tomography in optic pit and associated maculopathy]. Ophthalmologe (2004) 0.75
Histopathology of optic nerve pit-associated maculopathy. Clin Ophthalmol (2012) 0.75
Optical coherence tomography findings and retinal changes after vitrectomy for optic disc pit maculopathy. Indian J Ophthalmol (2014) 0.75
Distichiasis-lymphedema syndrome with optic disc pit. Indian J Ophthalmol (2010) 0.75
Optic pit associated serous macular detachment. Int Ophthalmol (2006) 0.75
Functional microperimetry and SD-OCT confirm consecutive retinal atrophy from optic nerve pit. Clin Ophthalmol (2009) 0.75
The results of 25-gauge vitreoretinal surgery for optic disc pit-associated maculopathy: a report of three cases and mini-review of the literature. Int Ophthalmol (2016) 0.75
Identification of a gene that causes primary open angle glaucoma. Science (1997) 8.14
Effects of linkage on rates of molecular evolution. Proc Natl Acad Sci U S A (1988) 3.96
Use of chloramphenicol as topical eye medication: time to cry halt? BMJ (1995) 3.53
Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol (2000) 3.39
Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet (1999) 3.24
Ultrasound biomicroscopy in pigment dispersion syndrome. Ophthalmology (1994) 2.98
Prevent Blindness America visual field screening study. The Prevent Blindness America Glaucoma Advisory Committee. Am J Ophthalmol (1995) 2.88
Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. Ophthalmology (2000) 2.70
Evaluating NHS direct. Early findings raise questions about expanding the service. BMJ (1999) 2.45
Tolterodine: a safe and effective treatment for older patients with overactive bladder. J Am Geriatr Soc (2001) 2.44
Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. Am J Hum Genet (1998) 2.34
Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol (1997) 2.31
Factors affecting image acquisition during scanning laser polarimetry. Ophthalmic Surg Lasers (1998) 2.23
Prevention of blinking alters iris configuration in pigment dispersion syndrome and in normal eyes. Ophthalmology (1995) 2.21
Persistence of tandem arrays: implications for satellite and simple-sequence DNAs. Genetics (1987) 2.20
Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol (2000) 2.13
The discriminant value of semiquantitative SPECT data in mild Alzheimer's disease. J Nucl Med (1994) 2.00
Structural and functional assessment of the macular region in patients with glaucoma. Br J Ophthalmol (2006) 1.92
Racial differences in optic nerve head parameters. Arch Ophthalmol (1989) 1.92
Pulsed Doppler echocardiographic determination of time of ductal closure in normal newborn infants. J Pediatr (1981) 1.89
An interocular comparison of the multifocal VEP: a possible technique for detecting local damage to the optic nerve. Invest Ophthalmol Vis Sci (2000) 1.88
Do patient age and medical condition influence medical advice to stop smoking? Age Ageing (2000) 1.83
Prevalence of pigment dispersion syndrome in a population undergoing glaucoma screening. Am J Ophthalmol (1993) 1.71
Effects of burglary on elderly people. BMJ (1989) 1.70
Ultrasound biomicroscopy in plateau iris syndrome. Am J Ophthalmol (1992) 1.70
Successful multimodal therapy for kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon: case report and review of the literature. Pediatr Hematol Oncol (1998) 1.64
Late infectious endophthalmitis from exposed glaucoma setons. Arch Ophthalmol (1992) 1.58
Cutaneous Bowen's disease. An analysis of 1001 cases according to age, sex, and site. J Am Acad Dermatol (1992) 1.56
Age-related decline of disc rim area in visually normal subjects. Ophthalmology (1992) 1.55
The clinical dementia rating sum of box score in mild dementia. Dement Geriatr Cogn Disord (2005) 1.54
Heidelberg retina tomography and optical coherence tomography in normal, ocular-hypertensive, and glaucomatous eyes. Ophthalmology (1999) 1.53
New patterns of infecting organisms in late bleb-related endophthalmitis: a ten year review. Eye (Lond) (1998) 1.53
Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology (1991) 1.52
S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma. Invest Ophthalmol Vis Sci (1989) 1.50
Measurement of ultrasound biomicroscopy images: intraobserver and interobserver reliability. Invest Ophthalmol Vis Sci (1994) 1.50
Quantitative assessment of the anterior segment using ultrasound biomicroscopy. Curr Opin Ophthalmol (2000) 1.50
Initial 5-fluorouracil trabeculectomy in uncomplicated glaucoma. Ophthalmology (1991) 1.50
Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol (1998) 1.48
Reproducibility of retinal thickness measurements in normal eyes using optical coherence tomography. Ophthalmic Surg Lasers (1998) 1.47
Differential diagnosis of dementia: a prospective evaluation of the DAT Inventory. J Am Geriatr Soc (1994) 1.47
The Glaucoma Symptom Scale. A brief index of glaucoma-specific symptoms. Arch Ophthalmol (1998) 1.46
Ultrasound biomicroscopy in pseudophakic malignant glaucoma. Ophthalmology (1993) 1.46
Bleb-related ocular infection in children after trabeculectomy with mitomycin C. Ophthalmology (1997) 1.46
Compliance with continuous positive airway pressure therapy: assessing and improving treatment outcomes. Curr Opin Pulm Med (2001) 1.44
Antimyosin antibody imaging in experimental aortic regurgitation. J Nucl Cardiol (1997) 1.42
Combined phacoemulsification and goniosynechialysis for uncontrolled chronic angle-closure glaucoma after acute angle-closure glaucoma. Ophthalmology (1999) 1.42
Length of stay. How short should hospital care be? Eur J Public Health (2001) 1.41
Soft contact lens modification of the ocular cup for high-resolution ultrasound biomicroscopy. Ophthalmic Surg (1993) 1.40
Multiple sclerosis and non-communicating syringomyelia: a casual association or linked diseases? Acta Neurol Scand (1999) 1.38
Congenital ectropion uveae with glaucoma. Ophthalmology (1984) 1.37
Intraocular suture ligature to reduce hypotony following Molteno seton implantation. Ophthalmic Surg (1992) 1.37
Pericardial patch grafts in glaucoma implant surgery. J Glaucoma (1998) 1.30
Exfoliation syndrome and occludable angles. Trans Am Ophthalmol Soc (1994) 1.30
Clinical signs of the pseudoexfoliation syndrome. Ophthalmology (1986) 1.29
Treatment of the Weill-Marchesani syndrome. Ann Ophthalmol (1981) 1.29
Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens. J Infect Dis (1999) 1.28
Optical coherence tomography and scanning laser polarimetry in normal, ocular hypertensive, and glaucomatous eyes. Am J Ophthalmol (2000) 1.27
Ocular findings in oculodermal melanocytosis. Arch Ophthalmol (1990) 1.26
Increase in iris-lens contact after laser iridotomy for pupillary block angle closure. Am J Ophthalmol (1996) 1.25
The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res (2001) 1.25
Preclinical diagnosis of pseudoexfoliation syndrome. Arch Ophthalmol (1987) 1.25
Hypertensive retinopathy. Description, classification, and prognosis. Ophthalmology (1982) 1.23
Optic coherence tomography of optic disk pit maculopathy. Am J Ophthalmol (1996) 1.23
Clinical governance. Thin on the ground. Health Serv J (1999) 1.23
Clinical governance in primary care: organisational development for clinical governance. BMJ (2000) 1.22
Drusen of the optic disc. Surv Ophthalmol (1977) 1.21
Retinal fat emboli as sequela to acute pancreatitis. Am J Ophthalmol (1975) 1.21
Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats. Neurosci Lett (2001) 1.21
Stem cells and differentiation stages in the limbo-corneal epithelium. Prog Retin Eye Res (2000) 1.21
Effect of a tight necktie on intraocular pressure. Br J Ophthalmol (2003) 1.19
Argon laser peripheral iridoplasty. Ophthalmic Surg Lasers (1996) 1.19
Differential diagnosis of anterior segment cysts by ultrasound biomicroscopy. Ophthalmology (1999) 1.18
Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS). Osteoporos Int (2010) 1.18
A comparison between microperimetry and standard achromatic perimetry of the central visual field in eyes with glaucomatous paracentral visual-field defects. Br J Ophthalmol (2009) 1.17
Ultrasound biomicroscopy dark room provocative testing: a quantitative method for estimating anterior chamber angle width. Jpn J Ophthalmol (2000) 1.17
Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. Int J Impot Res (2001) 1.16
Atmospheric trends in methylchloroform and the global average for the hydroxyl radical. Science (1987) 1.16
Coherent X-ray diffractive imaging: applications and limitations. Opt Express (2003) 1.15